Vtv Therapeutics Inc. insider trading

Does following Vtv Therapeutics Inc.’s insiders pay?

From August 11, 2015 to November 19, 2024, 7 insiders reported 65 open-market purchases and 1 sale not made under a pre-set plan in Vtv Therapeutics Inc. Twelve months after each purchase was reported, the shares were −22.1% against the S&P 500 on average (median −29.7%), over 22 purchases with a full year of prices; 18% beat the index. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on August 12, 2015 into $7,209 by November 2, 2026, −2.9% a year. It held shares 39% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $17,063 (+4.9% a year), and held throughout $43,538 (+14.0%).

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.